Corticosteroids for IBD linked with adverse perinatal outcomes: study
Disease remission should be confirmed prior to pregnancy, gastroenterologists say
Infants born to women with inflammatory bowel disease who are exposed to corticosteroids in utero risk increased rates of adverse events, warn the authors of a prospective cohort study.
The findings emphasise the importance of preconception counselling to confirm remission and maintaining stable steroid-sparing therapy during pregnancy, the US team says.
Women enrolled in the national Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes Registry were followed from four
